{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T14:09:53Z","timestamp":1696687793013},"reference-count":80,"publisher":"The Japanese Society for Medical Mycology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nippon Ishinkin Gakkai Zasshi","Jpn. J. Med. Mycol.","Japanese Journal of Medical Mycology"],"published-print":{"date-parts":[[2009]]},"DOI":"10.3314\/jjmm.50.057","type":"journal-article","created":{"date-parts":[[2009,5,11]],"date-time":"2009-05-11T05:57:38Z","timestamp":1242021458000},"page":"057-066","source":"Crossref","is-referenced-by-count":5,"title":["The Mechanisms of Resistance to Echinocandin Class of Antifungal Drugs"],"prefix":"10.3314","volume":"50","author":[{"given":"Kyoko","family":"Niimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1842","reference":[{"issue":"12","key":"1","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1128\/AAC.38.12.2750","volume":"38","year":"1994","ISSN":"http:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2)Denning DW: Echinocandins and pneumocandins--a new antifungal class with a novel mode of action. J Antimicrob Chemother 40: 611-614, 1997.","DOI":"10.1093\/jac\/40.5.611"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jim.7000091"},{"issue":"3","key":"4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1271\/kagakutoseibutsu1962.39.154","volume":"39","author":"HORI YASUHIRO","year":"2001","ISSN":"http:\/\/id.crossref.org\/issn\/0453-073X","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5)\u6c60\u7530\u6587\u662d:\u30ad\u30e3\u30f3\u30c7\u30a3\u30f3\u7cfb\u6297\u771f\u83cc\u85ac\u30df\u30ab\u30d5\u30a1\u30f3\u30ae\u30f3. \u771f\u83cc\u8a8c 46: 217-222, 2005.","DOI":"10.3314\/jjmm.46.217"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6)Wagner C, Graninger W, Presterl E, Joukhadar C: The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications. Pharmacology 78: 161-177, 2006.","DOI":"10.1159\/000096348"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7)Kauffman CA, Carver PL: Update on echinocandin antifungals. Semin Respir Crit Care Med 29: 211-219, 2008.","DOI":"10.1055\/s-2008-1063859"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8)Bachmann SP, Patterson TF, Lopez-Ribot JL: In vitro activity of caspofungin(MK-0991)against Candida albicans clinical isolates displaying different mechanisms of azole resistance. J Clin Microbiol 40: 2228-2230, 2002.","DOI":"10.1128\/JCM.40.6.2228-2230.2002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9)Messer SA, Diekema DJ, Boyken L, Tendolkar S, Hollis RJ, Pfaller MA: Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp. J Clin Microbiol 44: 324-326, 2006.","DOI":"10.1128\/JCM.44.2.324-326.2006"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10)Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ: In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J Clin Microbiol 46: 150-156, 2008.","DOI":"10.1128\/JCM.01901-07"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11)Bachmann SP, VandeWalle K, Ramage G, Patterson TF, Wickes BL, Graybill JR, Lopez-Ribot JL: In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 46: 3591-3596, 2002.","DOI":"10.1128\/AAC.46.11.3591-3596.2002"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1093\/jmicro\/51.4.247"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1093\/jmicro\/dfh100"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14)Bowman JC, Hicks PS, Kurtz MB, Rosen H, Schmatz DM, Liberator PA, Douglas CM: The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro. Antimicrob Agents Chemother 46: 3001-3012, 2002.","DOI":"10.1128\/AAC.46.9.3001-3012.2002"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1128\/JB.183.7.2273-2279.2001"},{"issue":"1","key":"16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/AAC.44.1.57-62.2000","volume":"44","author":"TAWARA S","year":"2000","ISSN":"http:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17)Garcia-Effron G, Park S, Perlin DS: Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for C. albicans: implications for interpretive breakpoints. Antimicrob Agents Chemother 53: 112-122, 2009.","DOI":"10.1128\/AAC.01162-08"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18)Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S: National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother 53: 283-289, 2004.","DOI":"10.1093\/jac\/dkh053"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19)Pfaller MA, Boyken L, Hollis RJ, Messer SA, Tendolkar S, Diekema DJ: Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods. J Clin Microbiol 44: 3533-3538, 2006.","DOI":"10.1128\/JCM.00872-06"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20)Lass-Florl C, Mayr A, Perkhofer S, Hinterberger G, Hausdorfer J, Speth C, Fille M: Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother 52: 3637-3641, 2008.","DOI":"10.1128\/AAC.00662-08"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21)Nakai T, Uno J, Ikeda F, Tawara S, Nishimura K, Miyaji M: In vitro antifungal activity of micafungin(FK463)against dimorphic fungi: comparison of yeast-like and mycelial forms. Antimicrob Agents Chemother 47: 1376-1381, 2003.","DOI":"10.1128\/AAC.47.4.1376-1381.2003"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.16.5808"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5259.279"},{"issue":"13","key":"24","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1128\/jb.179.13.4096-4105.1997","volume":"179","year":"1997","ISSN":"http:\/\/id.crossref.org\/issn\/0021-9193","issn-type":"print"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25)Ohyama T, Miyakoshi S, Isono F: FKS1 mutations responsible for selective resistance of Saccharomyces cerevisiae to the novel 1,3-beta-glucan synthase inhibitor arborcandin C. Antimicrob Agents Chemother 48: 319-322, 2004.","DOI":"10.1128\/AAC.48.1.319-322.2004"},{"issue":"10","key":"26","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1128\/MCB.15.10.5671","volume":"15","year":"1995","ISSN":"http:\/\/id.crossref.org\/issn\/0270-7306","issn-type":"print"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00200-06"},{"issue":"11","key":"28","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.41.11.2471","volume":"41","year":"1997","ISSN":"http:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"issue":"2","key":"29","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/JB.181.2.444-453.1999","volume":"181","author":"THOMPSON J R","year":"1999","ISSN":"http:\/\/id.crossref.org\/issn\/0021-9193","issn-type":"print"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00030-06"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(84)81032-7"},{"issue":"2","key":"32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.7164\/antibiotics.55.219","volume":"55","author":"HATANO K","year":"2002","ISSN":"http:\/\/id.crossref.org\/issn\/0021-8820","issn-type":"print"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33)Laverdiere M, Lalonde RG, Baril JG, Sheppard DC, Park S, Perlin DS: Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis. J Antimicrob Chemother 57: 705-708, 2006.","DOI":"10.1093\/jac\/dkl022"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34)Baixench MT, Aoun N, Desnos-Ollivier M, Garcia-Hermoso D, Bretagne S, Ramires S, Piketty C, Dannaoui E: Acquired resistance to echinocandins in Candida albicans: case report and review. J Antimicrob Chemother 59: 1076-1083, 2007.","DOI":"10.1093\/jac\/dkm095"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35)Cleary JD, Garcia-Effron G, Chapman SW, Perlin DS: Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment. Antimicrob Agents Chemother 52: 2263-2265, 2008.","DOI":"10.1128\/AAC.01568-07"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36)Miller CD, Lomaestro BW, Park S, Perlin DS: Progressive esophagitis caused by Candida albicans with reduced susceptibility to caspofungin. Pharmacotherapy 26: 877-880, 2006.","DOI":"10.1592\/phco.26.6.877"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37)Park S, Kelly R, Kahn JN, Robles J, Hsu MJ, Register E, Li W, Vyas V, Fan H, Abruzzo G, Flattery A, Gill C, Chrebet G, Parent SA, Kurtz M, Teppler H, Douglas CM, Perlin DS: Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates. Antimicrob Agents Chemother 49: 3264-3273, 2005.","DOI":"10.1128\/AAC.49.8.3264-3273.2005"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38)Katiyar S, Pfaller M, Edlind T: Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility. Antimicrob Agents Chemother 50: 2892-2894, 2006.","DOI":"10.1128\/AAC.00349-06"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39)Thompson GR, 3rd, Wiederhold NP, Vallor AC, Villareal NC, Lewis JS, 2nd, Patterson TF: Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection. Antimicrob Agents Chemother 52: 3783-3785, 2008.","DOI":"10.1128\/AAC.00473-08"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40)Desnos-Ollivier M, Bretagne S, Raoux D, Hoinard D, Dromer F, Dannaoui E: Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing. Antimicrob Agents Chemother 52: 3092-3098, 2008.","DOI":"10.1128\/AAC.00088-08"},{"issue":"18","key":"41","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1128\/jb.176.18.5686-5696.1994","volume":"176","year":"1994","ISSN":"http:\/\/id.crossref.org\/issn\/0021-9193","issn-type":"print"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42)Kurtz MB, Abruzzo G, Flattery A, Bartizal K, Marrinan JA, Li W, Milligan J, Nollstadt K, Douglas CM: Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies. Infect Immun 64: 3244-3251, 1996.","DOI":"10.1128\/IAI.64.8.3244-3251.1996"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43)Garcia-Effron G, Katiyar SK, Park S, Edlind TD, Perlin DS: A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility. Antimicrob Agents Chemother 52: 2305-2312, 2008.","DOI":"10.1128\/AAC.00262-08"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44)Perlin DS: Resistance to echinocandin-class antifungal drugs. Drug Resist Updat 10: 121-130, 2007.","DOI":"10.1016\/j.drup.2007.04.002"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00917-07"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46)Arendrup MC, Perkhofer S, Howard SJ, Garcia-Effron G, Vishukumar A, Perlin D, Lass-Florl C: Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins. Antimicrob Agents Chemother 52: 3504-3511, 2008.","DOI":"10.1128\/AAC.00190-08"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47)Lesage G, Sdicu AM, Menard P, Shapiro J, Hussein S, Bussey H: Analysis of beta-1,3-glucan assembly in Saccharomyces cerevisiae using a synthetic interaction network and altered sensitivity to caspofungin. Genetics 167: 35-49, 2004.","DOI":"10.1534\/genetics.167.1.35"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48)Reinoso-Martin C, Schuller C, Schuetzer-Muehlbauer M, Kuchler K: The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling. Eukaryot Cell 2: 1200-1210, 2003.","DOI":"10.1128\/EC.2.6.1200-1210.2003"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49)Liu TT, Lee RE, Barker KS, Wei L, Homayouni R, Rogers PD: Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 49: 2226-2236, 2005.","DOI":"10.1128\/AAC.49.6.2226-2236.2005"},{"key":"50","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.69.2.262-291.2005"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51)Bruno VM, Kalachikov S, Subaran R, Nobile CJ, Kyratsous C, Mitchell AP: Control of the C. albicans cell wall damage response by transcriptional regulator Cas5. PLoS Pathog 2: 204-210, 2006.","DOI":"10.1371\/journal.ppat.0020021"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52)Rauceo JM, Blankenship JR, Fanning S, Hamaker JJ, Deneault JS, Smith FJ, Nantel A, Mitchell AP: Regulation of the Candida albicans cell wall damage response by transcription factor Sko1 and PAS kinase Psk1. Mol Biol Cell 19: 2741-2751, 2008.","DOI":"10.1091\/mbc.e08-02-0191"},{"key":"53","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2003.03495.x"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54)Cannon RD, Lamping E, Holmes AR, Niimi K, Tanabe K, Niimi M, Monk BC: Candida albicans drug resistance another way to cope with stress. Microbiology 153: 3211-3217, 2007.","DOI":"10.1099\/mic.0.2007\/010405-0"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55)Walker LA, Munro CA, de Bruijn I, Lenardon MD, McKinnon A, Gow NA: Stimulation of chitin synthesis rescues Candida albicans from echinocandins. PLoS Pathog 4: 1-12, 2008.","DOI":"10.1371\/journal.ppat.1000040"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56)Steinbach WJ, Cramer RA, Jr., Perfect BZ, Henn C, Nielsen K, Heitman J, Perfect JR: Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus. Antimicrob Agents Chemother 51: 2979-2981, 2007.","DOI":"10.1128\/AAC.01394-06"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57)Kontoyiannis DP, Lewis RE, Osherov N, Albert ND, May GS: Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species. J Antimicrob Chemother 51: 313-316, 2003.","DOI":"10.1093\/jac\/dkg090"},{"key":"58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0813394106"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59)Hodgetts S, Nooney L, Al-Akeel R, Curry A, Awad S, Matthews R, Burnie J: Efungumab and caspofungin: pre-clinical data supporting synergy. J Antimicrob Chemother 61: 1132-1139, 2008.","DOI":"10.1093\/jac\/dkn075"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60)Stevens DA, White TC, Perlin DS, Selitrennikoff CP: Studies of the paradoxical effect of caspofungin at high drug concentrations. Diagn Microbiol Infect Dis 51: 173-178, 2005.","DOI":"10.1016\/j.diagmicrobio.2004.10.006"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61)Wiederhold NP: Attenuation of echinocandin activity at elevated concentrations: a review of the paradoxical effect. Curr Opin Infect Dis 20: 574-578, 2007.","DOI":"10.1097\/QCO.0b013e3282f1be7f"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62)Stevens DA, Ichinomiya M, Koshi Y, Horiuchi H: Escape of Candida from caspofungin inhibition at concentrations above the MIC(paradoxical effect)accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin. Antimicrob Agents Chemother 50: 3160-3161, 2006.","DOI":"10.1128\/AAC.00563-06"},{"key":"63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2007.05588.x"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64)Wiederhold NP, Kontoyiannis DP, Prince RA, Lewis RE: Attenuation of the activity of caspofungin at high concentrations against Candida albicans: possible role of cell wall integrity and calcineurin pathways. Antimicrob Agents Chemother 49: 5146-5148, 2005.","DOI":"10.1128\/AAC.49.12.5146-5148.2005"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65)Chamilos G, Lewis RE, Albert N, Kontoyiannis DP: Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences. Antimicrob Agents Chemother 51: 2257-2259, 2007.","DOI":"10.1128\/AAC.00095-07"},{"issue":"11","key":"66","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.39.11.2378","volume":"39","year":"1995","ISSN":"http:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67)Maebashi K, Niimi M, Kudoh M, Fischer FJ, Makimura K, Niimi K, Piper RJ, Uchida K, Arisawa M, Cannon RD, Yamaguchi H: Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients. J Antimicrob Chemother 47: 527-536, 2001.","DOI":"10.1093\/jac\/47.5.527"},{"key":"68","unstructured":"68)Cannon RD, Lamping E, Holmes AR, Niimi K, Baret PV, Keniya MV, Tanabe K, Niimi M, Goffeau A, Monk BC: Efflux-mediated fungal drug resistance. Clin Rev Microbiol(In press)"},{"key":"69","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2003.03430.x"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70)Niimi K, Maki K, Ikeda F, Holmes AR, Lamping E, Niimi M, Monk BC, Cannon RD: Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility. Antimicrob Agents Chemother 50: 1148-1155, 2006.","DOI":"10.1128\/AAC.50.4.1148-1155.2006"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71)Silver PM, Oliver BG, White TC: Characterization of caspofungin susceptibilities by broth and agar in Candida albicans clinical isolates with characterized mechanisms of azole resistance. Med Mycol 46: 231-239, 2008.","DOI":"10.1080\/13693780701816557"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72)Richards TS, Oliver BG, White TC: Micafungin activity against Candida albicans with diverse azole resistance phenotypes. J Antimicrob Chemother 62: 349-355, 2008.","DOI":"10.1093\/jac\/dkn156"},{"key":"73","doi-asserted-by":"publisher","DOI":"10.1002\/yea.818.abs"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74)Hernandez S, Lopez-Ribot JL, Najvar LK, McCarthy DI, Bocanegra R, Graybill JR: Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis. Antimicrob Agents Chemother 48: 1382-1383, 2004.","DOI":"10.1128\/AAC.48.4.1382-1383.2004"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75)Moudgal V, Little T, Boikov D, Vazquez JA: Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis. Antimicrob Agents Chemother 49: 767-769, 2005.","DOI":"10.1128\/AAC.49.2.767-769.2005"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76)Maligie MA, Selitrennikoff CP: Cryptococcus neoformans resistance to echinocandins:(1,3)beta-glucan synthase activity is sensitive to echinocandins. Antimicrob Agents Chemother 49: 2851-2856, 2005.","DOI":"10.1128\/AAC.49.7.2851-2856.2005"},{"key":"77","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.3.739-746.2000"},{"key":"78","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1680"},{"key":"79","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01653-05"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80)Garcia-Effron G, Kontoyiannis DP, Lewis RE, Perlin DS: Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies. Antimicrob Agents Chemother 52: 4181-4183, 2008.","DOI":"10.1128\/AAC.00802-08"}],"container-title":["Nippon Ishinkin Gakkai Zasshi"],"original-title":[],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T17:25:34Z","timestamp":1621531534000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jjmm\/50\/2\/50_2_057\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.3314\/jjmm.50.057","relation":{},"ISSN":["0916-4804","1882-0476"],"issn-type":[{"value":"0916-4804","type":"print"},{"value":"1882-0476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}